NFKB1 and irritable bowel syndrome: One of the most studied inflammatory pathways in IBD is the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) signaling pathway which involves hyper-activation in epithelial or immune cells from IBD patients [51].